FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037344028> ?p ?o ?g. }

• W3037344028 endingPage "1846" @default.
• W3037344028 startingPage "1836" @default.
• W3037344028 abstract "Significance Statement Association of fibroblast growth factor 23 (FGF23) with risk of infection has not been evaluated in a CKD population. Among 3655 participants of the Chronic Renal Insufficiency Cohort (CRIC) study who had nondialysis-dependent CKD, higher baseline plasma levels of C-terminal FGF23 were significantly and monotonically associated with time to first hospitalization with major infection, independent of biomarkers of inflammation or bone mineral metabolism. These findings suggest a possible role of FGF23 in the increased susceptibility to infection among individuals with CKD. The most frequent infections were of the urinary tract, followed by cellulitis/osteomyelitis, pneumonia, and then bacteremia/septicemia. Background Risk of infectious disease is increased among individuals with CKD. Fibroblast growth factor 23 (FGF23) is often elevated in CKD, and may impair immune function directly or indirectly through proinflammatory and vitamin D–suppressing pathways. Whether FGF23 is associated with risk of infection has not been evaluated in a CKD population. Methods In 3655 participants of the Chronic Renal Insufficiency Cohort study, we evaluated the association of baseline plasma levels of C-terminal FGF23 with time to first hospitalization with major infection, defined by hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyelitis, or bacteremia/septicemia. Multivariable Cox models were used to estimate hazard ratios (HRs) and adjust for confounding. Results During a median follow-up of 6.5 years, 1051 individuals (29%) were hospitalized with major infection. Multivariable Cox analysis indicated a graded increase in the risk of infection with higher levels of FGF23 (HR, 1.51; 95% CI, 1.23 to 1.85 with the highest quartile [≥235.9 RU/ml] versus lowest quartile [<95.3 RU/ml]; HR, 1.26; 95% CI, 1.18 to 1.35 per SD increment in log FGF23). The association was consistent across infection subtypes and demographic and clinical subgroups, and remained significant after additional adjustment for biomarkers of inflammation (IL-6, TNF- α , high-sensitivity C-reactive protein, fibrinogen, and albumin), and bone mineral metabolism (25-hydroxyvitamin D, phosphorus, calcium, and parathyroid hormone). The association was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomyelitis (422 cases), pneumonia (399 cases), and bacteremia/septicemia (280 cases). Conclusions Among individuals with CKD, higher FGF23 levels were independently and monotonically associated with an increased risk of hospitalization with infection." @default.
• W3037344028 created "2020-07-02" @default.
• W3037344028 creator A5003850042 @default.
• W3037344028 creator A5005612663 @default.
• W3037344028 creator A5008906136 @default.
• W3037344028 creator A5011689889 @default.
• W3037344028 creator A5016894949 @default.
• W3037344028 creator A5033935081 @default.
• W3037344028 creator A5037215503 @default.
• W3037344028 creator A5047317486 @default.
• W3037344028 creator A5047540616 @default.
• W3037344028 creator A5048680434 @default.
• W3037344028 creator A5050661309 @default.
• W3037344028 creator A5055512614 @default.
• W3037344028 creator A5069526163 @default.
• W3037344028 creator A5070158926 @default.
• W3037344028 creator A5071083375 @default.
• W3037344028 creator A5085929316 @default.
• W3037344028 creator A5086558284 @default.
• W3037344028 creator A5086744652 @default.
• W3037344028 date "2020-06-23" @default.
• W3037344028 modified "2023-10-16" @default.
• W3037344028 title "Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study" @default.
• W3037344028 cites W1678732033 @default.
• W3037344028 cites W1963306946 @default.
• W3037344028 cites W1977645780 @default.
• W3037344028 cites W1983098935 @default.
• W3037344028 cites W1983131663 @default.
• W3037344028 cites W1991297728 @default.
• W3037344028 cites W1995543125 @default.
• W3037344028 cites W2023869058 @default.
• W3037344028 cites W2078730571 @default.
• W3037344028 cites W2080664254 @default.
• W3037344028 cites W2089363189 @default.
• W3037344028 cites W2090490099 @default.
• W3037344028 cites W2094551185 @default.
• W3037344028 cites W2100168006 @default.
• W3037344028 cites W2107420262 @default.
• W3037344028 cites W2113048106 @default.
• W3037344028 cites W2117729914 @default.
• W3037344028 cites W2118625269 @default.
• W3037344028 cites W2124580054 @default.
• W3037344028 cites W2125404075 @default.
• W3037344028 cites W2143117346 @default.
• W3037344028 cites W2146045604 @default.
• W3037344028 cites W2146711269 @default.
• W3037344028 cites W2148983669 @default.
• W3037344028 cites W2150843151 @default.
• W3037344028 cites W2153955787 @default.
• W3037344028 cites W2180514454 @default.
• W3037344028 cites W2274689835 @default.
• W3037344028 cites W2361150752 @default.
• W3037344028 cites W2477224043 @default.
• W3037344028 cites W2550969996 @default.
• W3037344028 cites W2551373757 @default.
• W3037344028 cites W2746154771 @default.
• W3037344028 cites W2756972553 @default.
• W3037344028 cites W2766677984 @default.
• W3037344028 cites W2915967003 @default.
• W3037344028 doi "https://doi.org/10.1681/asn.2019101106" @default.
• W3037344028 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7460903" @default.
• W3037344028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32576601" @default.
• W3037344028 hasPublicationYear "2020" @default.
• W3037344028 type Work @default.
• W3037344028 sameAs 3037344028 @default.
• W3037344028 citedByCount "16" @default.
• W3037344028 countsByYear W30373440282020 @default.
• W3037344028 countsByYear W30373440282021 @default.
• W3037344028 countsByYear W30373440282022 @default.
• W3037344028 countsByYear W30373440282023 @default.
• W3037344028 crossrefType "journal-article" @default.
• W3037344028 hasAuthorship W3037344028A5003850042 @default.
• W3037344028 hasAuthorship W3037344028A5005612663 @default.
• W3037344028 hasAuthorship W3037344028A5008906136 @default.
• W3037344028 hasAuthorship W3037344028A5011689889 @default.
• W3037344028 hasAuthorship W3037344028A5016894949 @default.
• W3037344028 hasAuthorship W3037344028A5033935081 @default.
• W3037344028 hasAuthorship W3037344028A5037215503 @default.
• W3037344028 hasAuthorship W3037344028A5047317486 @default.
• W3037344028 hasAuthorship W3037344028A5047540616 @default.
• W3037344028 hasAuthorship W3037344028A5048680434 @default.
• W3037344028 hasAuthorship W3037344028A5050661309 @default.
• W3037344028 hasAuthorship W3037344028A5055512614 @default.
• W3037344028 hasAuthorship W3037344028A5069526163 @default.
• W3037344028 hasAuthorship W3037344028A5070158926 @default.
• W3037344028 hasAuthorship W3037344028A5071083375 @default.
• W3037344028 hasAuthorship W3037344028A5085929316 @default.
• W3037344028 hasAuthorship W3037344028A5086558284 @default.
• W3037344028 hasAuthorship W3037344028A5086744652 @default.
• W3037344028 hasBestOaLocation W30373440281 @default.
• W3037344028 hasConcept C114276007 @default.
• W3037344028 hasConcept C126322002 @default.
• W3037344028 hasConcept C201903717 @default.
• W3037344028 hasConcept C203014093 @default.
• W3037344028 hasConcept C2777238321 @default.
• W3037344028 hasConcept C2778653478 @default.
• W3037344028 hasConcept C2779443120 @default.
• W3037344028 hasConcept C2781208988 @default.

• next